FePt nanoparticles: a novel nanoprobe for enhanced HeLa cells sensitivity to chemoradiotherapy,RSC Advances

当前位置： X-MOL 学术 › RSC Adv. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

FePt nanoparticles: a novel nanoprobe for enhanced HeLa cells sensitivity to chemoradiotherapy
RSC Advances ( IF 3.9 ) Pub Date : 2016-04-04 00:00:00 , DOI: 10.1039/c6ra03990a
Zhirong Bao _{1,

2,

3,

4} , Mingyang He _{2,

4,

5,

6} , Hong Quan _{1,

2,

3,

4} , Dazhen Jiang _{1,

2,

3,

4} , Yanhong Zheng _{4,

7,

8,

9,

10} , Wenjing Qin _{1,

2,

3,

4} , Yunfeng Zhou _{4,

11,

12} , Feng Ren _{1,

2,

3,

4} , Mingxiong Guo _{2,

4,

5,

6} , Changzhong Jiang _{1,

2,

3,

4}

Affiliation

Chemoradiotherapy is a well-established treatment paradigm in oncology to consistently improve local tumor control compared to sole administration of chemotherapy or radiotherapy. Despite its importance, few agents have been identified...

中文翻译：